Treatments Help Long-term Outcomes of Critical COVID Illness

Use of interleukin 6 receptor antagonists and antiplatelet agents was associated with better survival rates and higher quality of life at 6 months.
Medscape Medical News

source https://www.medscape.com/viewarticle/986848?src=rss